Extendicare Inc's stock has seen a notable uptick, gaining 2.42% in the last trading session, reflecting investor confidence in its growth trajectory.
On the TSX, Extendicare Inc (EXE.TO) closed at CA$33.82, marking a 2.42% increase from the previous day. This rise can be attributed to the company's ongoing expansion and strategic acquisitions in the home health care sector, which have bolstered its market position and earnings potential.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.51B
P/E
27.2x
52W high
$37.59
52W low
$11.86
1W change
+0.27%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 3.2% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.28
+3.2% Upside
Current Price
C$37.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
25.2%
Annualized
90-Day Vol
33.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.35
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$39.38 | C$36.10 โ C$42.95 |
| 60 trading days | C$41.79 | C$36.96 โ C$47.25 |
| 90 trading days | C$44.35 | C$38.16 โ C$51.55 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of Extendicare's recent growth initiatives and financial performance, particularly in the context of the aging population and increasing demand for health care services.
Extendicare's Market Cap Reaches CA$3.09 Billion
With a market cap of CA$3.09 billion and a P/E ratio of 24.28, Extendicare is positioned as a key player in the health care sector, reflecting its growth potential amidst increasing demand.
Bull case
The recent acquisition of CBI Home Health for $570 million enhances Extendicare's service offerings in the home health care sector. This move is expected to significantly boost the company's earnings, especially as the demand for home health services continues to rise with an aging population. Additionally, a strong increase in adjusted EBITDA shows a positive growth trend. The company's decision to raise its dividend also signals confidence in its financial stability and long-term profitability.
Bear case
While the stock has risen, investors should stay cautious about potential market volatility. There are risks associated with the health care sector, including regulatory changes and economic pressures that could affect profitability.
Advertisement
